The PEARL Trial Is In: What Low-Dose Rapamycin Actually Did to Human Aging Over 48 Weeks
The most anticipated longevity drug trial in a generation has delivered its full one-year results. Here is what rapamycin actually did to lean muscle, pain, biological age, and overall healthspan…
